Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-12 20:49 | English | 36.0 KB | |||
| 2023-10-11 17:35 |
Egetis Therapeutics publishes prospectus for admission to trading of shares, in…
|
English | 60.1 KB | ||
| 2023-10-11 17:35 |
Egetis Therapeutics offentliggör prospekt för upptagande till handel av aktier,…
|
Swedish | 63.6 KB | ||
| 2023-10-10 22:35 |
Egetis Therapeutics has secured approximately SEK 462 million in a combined fin…
|
English | 99.6 KB | ||
| 2023-10-10 22:35 |
Egetis Therapeutics har säkrat cirka 462 miljoner kronor i en kombinerad finans…
|
Swedish | 99.5 KB | ||
| 2023-08-22 07:00 | Swedish | 4.1 MB | |||
| 2023-08-22 07:00 | English | 3.7 MB | |||
| 2023-06-28 23:30 |
Egetis tillkännager aktivering av första deltagande sjukhus för den i USA regis…
|
Swedish | 84.9 KB | ||
| 2023-06-28 23:30 |
Egetis announces site activation in the pivotal ReTRIACt trial for Emcitate® an…
|
English | 79.2 KB | ||
| 2023-06-13 14:18 | English | 34.0 KB | |||
| 2023-05-31 14:30 |
Board director in Egetis Therapeutics acquires shares
|
English | 55.5 KB | ||
| 2023-05-31 14:30 |
Styrelseledamot i Egetis Therapeutics förvärvar aktier
|
Swedish | 56.5 KB | ||
| 2023-05-23 21:02 |
Egetis announces termination of discussions regarding a potential acquisition o…
|
English | 78.6 KB | ||
| 2023-05-23 21:02 |
Egetis meddelar att diskussionerna om ett potentiellt förvärv av Bolaget har av…
|
Swedish | 78.8 KB | ||
| 2023-04-27 16:14 |
Bulletin from Egetis Therapeutics’ Annual General Meeting 2023
|
English | 63.2 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
